A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but ...
SHANGHAI—Chinese biotech companies, rapidly evolving from manufacturers of low-end generic drugs to serious competitors to American pharma giants, are training their sights on one of the most ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Sara Carter speaks at the Conservative Political Action Conference (CPAC) annual meeting in National Harbor, Maryland, ...
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...
Finding innovative ways to treat cancer is Pfizer’s biggest priority so to boost cutting-edge technologies, Pfizer executives went to Shenyang, China. There, last summer, Pfizer paid $1.25 billion to ...
Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next ...
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry giants last year are poised to make further advances in 2026, the chairman ...
US House Committee Opens Investigation Into Merck, AbbVie China Drug Trials By Deena Beasley June 30 (Reuters) - The chair of the U.S. House Select Committee on China opened national security ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results